ACE2 and endothelial dysfunction: The underlying pathophysiological mechanisms involve a complex interplay of systemic inflammation, thromboinflammatory responses, direct myocardial injury via angiotensin-converting enzyme 2 (ACE2)-mediated viral entry, endothelial dysfunction, and exacerbation of pre-existing atherosclerotic or structural cardiac conditions [7,8].